Compare CCRN & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCRN | ABEO |
|---|---|---|
| Founded | 1986 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 315.1M | 280.2M |
| IPO Year | 2001 | 2005 |
| Metric | CCRN | ABEO |
|---|---|---|
| Price | $9.50 | $4.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | $14.15 | ★ $18.75 |
| AVG Volume (30 Days) | 547.2K | ★ 1.4M |
| Earning Date | 03-04-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.16 |
| EPS | N/A | ★ 1.01 |
| Revenue | ★ $816,484,000.00 | $2,998,000.00 |
| Revenue This Year | N/A | $1,276.65 |
| Revenue Next Year | $4.93 | $112.53 |
| P/E Ratio | ★ N/A | $4.29 |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $7.43 | $3.93 |
| 52 Week High | $15.30 | $7.54 |
| Indicator | CCRN | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 53.65 | 32.62 |
| Support Level | $7.68 | $4.00 |
| Resistance Level | $10.28 | $5.62 |
| Average True Range (ATR) | 0.40 | 0.20 |
| MACD | 0.00 | -0.05 |
| Stochastic Oscillator | 46.49 | 2.44 |
Cross Country Healthcare Inc is a healthcare workforce solutions company delivering an AI-powered digital platform and advisory services to help health systems manage their labor ecosystem. It operates through two reportable segments: Nursing and Allied Staffing, which generates maximum revenue and provides staffing, recruiting, total talent solutions, vendor neutral programs, managed service programs, education healthcare services, caregiver services to PACE programs and outsourcing services; and Physician Staffing, which provides licensed practitioners including certified registered nurse anesthetists, nurse practitioners and physician assistants on temporary assignments. The company recruits professionals nationally and places them with healthcare facilities across the United States.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.